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Naive CD4+ T cell differentiation into distinct subsets
of T helper (Th) cells is a pivotal process in the initi-
ation of the adaptive immune response. Allergens
predominantly stimulate Th2 cells, causing allergic
inflammation. However, why allergens induce Th2
cell differentiation is not well understood. Here we
show that group 2 innate lymphoid cells (ILC2s) are
required to mount a robust Th2 cell response to the
protease-allergen papain. Intranasal administration
of papain stimulated ILC2s and Th2 cells, causing
allergic lung inflammation and elevated immuno-
globulin E titers. This process was severely impaired
in ILC2-deficient mice. Whereas interleukin-4 (IL-4)
was dispensable for papain-induced Th2 cell differ-
entiation, ILC2-derived IL-13 was critical as it pro-
moted migration of activated lung dendritic cells
into the draining lymph node where they primed
naive T cells to differentiate into Th2 cells. Papain-
induced ILC2 activation and Th2 cell differentia-
tion was IL-33-dependent, suggesting a common
pathway in the initiation of Th2 cell responses to
allergen.
INTRODUCTION
Allergy is one of the most common health problems in the indus-
trialized world. A type 2 immune response is responsible for
most allergen-induced inflammation at mucosal surfaces and
is reflected in an overproduction of T helper 2 (Th2) cell-type
(type 2) cytokines and immunoglobulin E (IgE) (Pulendran and
Artis, 2012). Individuals might be sensitized to specific allergens,
which stimulate naive CD4+ T cells to differentiate into Th2 cells.
The reexposure of sensitized individuals to the same allergens
causes a robust stimulation of memory Th2 cells that secrete
the cardinal type 2 effector cytokines interleukin-4 (IL-4), IL-5,IL-9, and IL-13 (Kim et al., 2010; Lloyd and Hessel, 2010). In
parallel, antigen crosslinking of IgE bound to FcεRI on mast
cells and basophils leads to activation and degranulation, ampli-
fying allergic inflammation of the affected tissues. Currently, the
mechanisms by which allergens initiate the differentiation of
naive CD4+ T cells into Th2 cells during the sensitization phase
are not well understood. It is generally thought that the cytokine
environment dictates the differentiation of naive CD4+ T cells into
various populations of Th cells. IL-4 in particular is believed to be
critical for Th2 cell differentiation, and binding to its receptor
activates STAT6, which induces the expression of the key tran-
scription factor GATA3 and drives the production of type-2
cytokines. However, the initial source of IL-4 responsible for
the differentiation of naive CD4+ T cells into Th2 cells has been
unclear because multiple cell populations, including natural
killer T (NKT) cells, gd T cells, basophils, dendritic cells (DCs),
and naive CD4+ T cells can produce IL-4 (Weiss and Brown,
2001; Yamane and Paul, 2013). Moreover, Th2 cell differentiation
can also be induced in vitro in the absence of exogenous IL-4
by IL-2, which induces IL-4Ra expression (Liao et al., 2008).
Additionally, Th2 cell responses can be induced in vivo in IL-4-
or IL-4R-deficient mice, indicating that an IL-4-independent
pathway of Th2 cell differentiation exists. Currently, how IL-4-
independent development of Th2 cells occurs is not well
understood.
Notably, epithelial cell-derived cytokines, including IL-33,
thymic stromal lymphopoietin (TSLP), and IL-25, are known to
promote Th2 cell responses and allergic inflammation (Islam
and Luster, 2012). The receptors for these cytokines are ex-
pressed by a variety of cell types including DCs, basophils,
and NKT cells, but not naive CD4+ T cells. Mice deficient for
the IL-33 receptor, ST2, produce reduced amounts of IL-4 and
IL-5 in response to challenge with helminth antigen (Townsend
et al., 2000) and IL-33 has been reported to activate DCs and
induce allergic airway inflammation (Besnard et al., 2011). The
stimulation of DCs (Zhou et al., 2005) and basophils (Siracusa
et al., 2011) by TSLP is also thought to be critical for allergic
inflammation. Nevertheless, the exact mechanisms by which
these epithelial cell-derived cytokines promote Th2 cell differen-
tiation are still unclear.Immunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc. 425
Immunity
ILC2 Regulates Th2 Cell DifferentiationGroup 2 innate lymphoid cells (ILC2s, previously termed natu-
ral helper cells, nuocytes, or Ih2 cells) (Spits et al., 2013), recently
discovered in the gut (Moro et al., 2010; Neill et al., 2010; Price
et al., 2010) and airway mucosa of mice (Chang et al., 2011;
Halim et al., 2012a; Monticelli et al., 2011) and man (Mjo¨sberg
et al., 2011), are rapid and potent producers of the type 2 cyto-
kines IL-5 and IL-13. With the discovery of ILC2s, we now under-
stand that type 2 immunity comprises both innate and adaptive
components. Papain, a protease known to be allergenic to
humans and causes occupational asthma (Novey et al., 1979),
is often used as a model allergen. Subcutaneous injection of
papain into mice induces Th2 cell-mediated immunity (Tang
et al., 2010). We have previously shown that intranasal adminis-
tration of papain rapidly induces activation of lung IL-5 and
IL-13-producing ILC2s, lung eosinophilia, and mucus hyperpro-
duction in RAG-deficient mice. Thus, ILC2 activation can induce
T cell- and IgE-independent acute allergic lung inflammation
(Halim et al., 2012a). We also found that retinoic acid receptor
related orphan receptor alpha (RORa) is critical for ILC2 develop-
ment, and RORa-deficient Staggerer (Rorasg/sg) bone marrow
(BM)-transplanted (BMT) mice are specifically deficient for
ILC2s (Halim et al., 2012b; Wong et al., 2012). These mice fail
to develop acute type 2 lung inflammation after sensitization
with papain. Notably, Rorasg/sg CD4+ T cells are not intrinsically
impaired to develop into Th2 cells, and the observed defect in
acute type 2 inflammation can be attributed to the lack of func-
tional ILC2s in Rorasg/sg BMT mice. Because ILC2s are a potent
and early source of type 2 cytokines, we hypothesized that they
could influence the downstream adaptive Th2 cell response. To
test this hypothesis, we have examined the effects of ILC2-defi-
ciency on Th2 cell responses to papain. Here we show that ILC2s
were required for Th2-cell-mediated allergic lung inflammation.
IL-13 produced by activated ILC2s was critical for promoting
the migration of activated lung DCs to the draining lymph node
(LN), where they induced the differentiation of naive CD4+
T cells into Th2 cells. Thus, our data reveal how innate ILC2
can play a critical role in the generation of adaptive Th2 cell
responses to allergens.
RESULTS
Protease-Allergen Papain Induced a Strong Innate and
Adaptive Type-2 Immune Response
Mice were sensitized to Th2 cell-mediated allergic responses
by the intranasal administration of papain (or heat-inactivated
papain as a control) on days 0 and 1, followed by two challenges
on days 13 and 20 (Figure 1A). Serum IgE titers increased upon
sensitization and subsequent challenges (Figure 1B). Leuko-
cytes, including eosinophils and neutrophils, rapidly infiltrated
into bronchoalveolar lavage (BAL) and lung tissue following
sensitization, and low amounts of type 2 cytokines were de-
tected in the BAL on day 2 (Figures 1C and D). Activated ILC2s
rather than Th2 cells likely mediated these early responses to
papain, since similar responses were observed in Rag1/
mice that have ILC2s but lack T and B cells (see Figures S1A–
S1C available online). The subsequent challenge of papain-
sensitized mice induced the infiltration of substantially higher
numbers of eosinophils in the BAL (9-fold increase, p = 0.02)
and the lung (15-fold increase, p = 0.005) as well as significantly426 Immunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc.higher concentrations of type 2 cytokines in the BAL (p = 0.0002)
on day 21 (Figures 1C and D). Th2 cells likely mediated these
latter responses to papain since Rag1/ mice did not show
the augmented immune response (Figures S1A–S1C). In wild-
type (WT) mice, the draining mediastinal lymph nodes (mLN)
were enlarged with substantially increased numbers of CD4+
T cells andB cells on day 21 (data not shown). Notably, basophils
and mast cells were not detected in substantial numbers at the
time-points investigated.
To confirm the induction of papain-specific Th2 cells, we iso-
lated lymphocytes from the lungs, peripheral (inguinal) LNs
(pLN), and spleens of papain-treated or control mice on day 21
and restimulated them with recall-antigen (Figure 1E) or immobi-
lized anti-CD3ε plus anti-CD28 (Figure S1D). The in vitro-stimu-
lated lung lymphocytes from papain-treated, but not control,
mice produced IL-4, IL-5, and IL-13. We also analyzed the
expression of GATA3, a critical transcription factor for Th2 cell
differentiation (Zheng and Flavell, 1997), in CD4+ T cells on day
21 by flow cytometry (Figures S1E and S1F). Both the percent-
ages and the absolute numbers of GATA3+ CD4+ T cells were
higher in the mLNs of the papain-treated mice compared to con-
trol mice (Figures 1F and 1G).
To identify the cellular source of type 2 cytokines at various
time points, we stained for intracellular IL-5 and IL-13 and cell-
type-specific surface markers in the lung (Figure 1H) and mLN
(Figure S1I). As expected from our previous studies (Halim
et al., 2012a), IL-5+IL-13+ cells on day 2 were primarily ILC2s.
On day 21, the majority of IL-5+IL-13+ cells were CD4+ T cells
(Figure 1H), while ILC2s also expanded and comprised approx-
imately 30% of IL-5+IL-13+ cells in the lung on day 21 (Figure 1H;
Figures S1J and S1K). Thus, intranasal administration of papain
initially stimulated ILC2s and also induced Th2 cell differentia-
tion, whereas the subsequent challenges with papain stimulated
primed Th2 cells, resulting in type 2 cytokine production,
increased IgE titers, and eosinophilic lung inflammation.
ILC2s Were Required for Induction of the Adaptive
Type-2 Immune Response
On the basis of the above results, we hypothesized that ILC2s
promote Th2 cell differentiation in papain-treated mice. To test
this, we investigated the effects of ILC2-deficiency on Th2 cell
responses to papain. We have previously shown that the tran-
scription factor RORa is required for ILC2 development and
that transplantation of BM from RORa mutant Rorasg/sg mice
into irradiated WT mice generates ILC2-deficient mice (Halim
et al., 2012b; Wong et al., 2012). Importantly, Rora is not highly
expressed in other hematopoietic cells, including naive and
memory T cells (Figure S2A). We have also previously shown
that Rorasg/sg CD4+ T cells have no inherent defect in their
capacity to differentiate into Th2 cells in vitro, indicating that
RORa is not intrinsically required for Th2 cell differentiation
(Halim et al., 2012b). Thus, WT bone-marrow-transplanted (WT
BMT) and ILC2-deficient Rorasg/sg BMT mice were administered
papain as in Figure 1A, and Th2 cell responses were compared
after the second challenge (day 20). Rorasg/sg BMT mice had
strikingly fewer eosinophils in the BAL, lung, andmLN, and fewer
neutrophils, DCs, and CD4+ T cells in the lung parenchyma and
mLN than WT BMT mice (Figures 2A and 2B). The inability of
Rorasg/sg BMT mice to mount strong Th2 cell responses to
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Figure 1. ILC2s and CD4+ T Cells Collaborated in Protease Allergen-Driven Innate and Adaptive Type-2 Lung Inflammation
(A) Mice were sensitized by intranasal injection of 10 mg heat-inactivated (control) or active papain on days 0 and 1, followed by antigen challenge on days 13
and 20.
(B) Serum concentrations of IgE were quantified on the days indicated (C papain,B control).
(C–E) Mice injected with papain (-) or control (,) were sacrificed on days 2, 14, and 21, followed by the quantification of myeloid populations in the bron-
choalveolar lavage (BAL) and lung tissue by flow cytometry (C). Similarly, lung lymphoid populations were quantified. Cytokine concentrations in BAL were
quantified by ELISA (D). Lymphocytes from indicated tissues were restimulated in vitro with recall antigen, followed by measurement for cytokine production (E).
(F and G) Intracellular GATA3 was detected in CD4+ T cells from lung and mLN on day 21 following stimulation with papain (-) or control (,). Shown are percent
(F) and absolute numbers (G) of GATA3+ CD4+ T cells.
(H) Lung cells were stained for intracellular IL-5 and IL-13 and analyzed by flow cytometry. The percentage of total IL-5+IL-13+ lung cells wasmeasured in papain-
treated or control mice on days 2 and 21. Double-positive cells were gated (left) and analyzed for surface expression of CD3 and NK1.1 to distinguish
NK1.1CD3+ T cells from NK1.1CD3 ILC2s (for detailed analysis, see Figure S1). Cells were first gated for live (eFluor780) CD45+ cells. The absolute numbers
of lung IL-5+IL-13+ ILC2s (,) or CD4+ T cells (-) in papain-treated mice, and IL-5+IL-13+ CD4+ T cells in control mice ( ) were calculated on days 2 and 21.
Data are representative of at least three independent experiments. Mean ± SEM in (B)–(H), mean percent gated in H, * = p % 0.05 ** = p % 0.01 (two-tailed
Student’s t test). See also Figure S1.
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ILC2 Regulates Th2 Cell Differentiationpapain was further supported by the substantially lower amounts
of type 2 cytokines and the Th2 cell-associated chemokines
CCL22 and CCL17 (Bromley et al., 2008) in the BAL (Figures
2C and 2D) as compared to controls. Papain-challenged
Rorasg/sg BMT mice also displayed substantially reduced levels
of IgE in the serum (Figure 2E) and substantially lower numbers
of GATA3+ CD4+ T cells in the lung compared to WT BMT mice
(Figure 2F; Figure S2B). Furthermore, the in vitro restimulation
of lymphocytes from the lung and mLN of Rorasg/sg BMT mice
with recall-antigen resulted in substantially less type 2 cytokine
production than those from WT BMT mice (Figure 2G). Histolog-ical analyses also revealed substantially less mucus production
and inflammation in the lungs of Rorasg/sg BMT mice than WT
BMTmice (Figure 2H; Figures S2C–S2E). Together, these results
clearly demonstrate a profound defect in Th2 cell immunity in the
absence of ILC2s.
IL-4 Was Not Required for an Efficient Adaptive Th2 Cell
Immune Response to Inhaled Protease Allergen
Because IL-4 is thought to play a critical role in the differentiation
of naive CD4+ T cells into Th2 cells (Pulendran and Artis, 2012),
the above results suggested that ILC2s might be a source ofImmunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc. 427
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Figure 2. ILC2-Deficient Mice Were Incapable of Mounting an Effective Th2 Cell Response and Had Greatly Reduced Type 2 Lung
Inflammation
(A–G)WT (-) andRorasg/sg (,) BMTmice were treatedwith papain and analyzed on day 21 for myeloid cell numbers in themLN, lung, and BAL (A). Lymphoid cell
numbers were measured in the mLN and lung (B). The BAL was analyzed for concentrations of cytokines (C) and chemokines (D). Serum IgE concentrations were
measured (E). The absolute number of GATA3+ CD4+ T cells was determined in the lung and mLN (F). Cells were restimulated with recall antigen, followed by an
analysis for cytokine production in culture supernatant (G).
(H) Formalin-fixed tissue was analyzed by histology for mucus production in PAS stained sections.
Data are representative of at least three independent experiments. Scale bar represents 100 mm. Mean ± SEM in (A)–(G), * = p% 0.05 ** = p% 0.001 (two-tailed
Student’s t test). See also Figure S2.
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ILC2 Regulates Th2 Cell DifferentiationIL-4 in papain-treated mice. However, purified ILC2s produced
large amounts of IL-5 and IL-13 but very little IL-4 (Figures S3A
and S3B). To clarify the role of IL-4 in papain-induced Th2 cell
responses, we tested the activation of Th2 cells in Il4/ mice.
Unexpectedly, Il4/ mice mounted a strong Th2 cell response
to papain and they had comparable levels of eosinophils in the
BAL asWTmice, although lung eosinophil numbers were slightly
lower (Figure 3A). They also exhibited no substantial difference in
the numbers of CD4+ T cells in the lung and mLN (Figure 3B), the
amounts of IL-5 and IL-13 in the BAL (Figure 3C), or the number
of GATA3+ Th2 cells in the lung and mLN (Figure 3E; Figure S3C)
when compared to WT mice. As expected, Il4/ mice had no
detectable IL-4 in the BAL (Figure 3C), and no detectable serum
IgE (Figure 3D), which is known to be IL-4-dependent (Finkelman
et al., 1988). Thus, IL-4 was dispensable for papain-induced
Th2 cell generation, suggesting that ILC2s promote Th2 cell
responses by an IL-4-independent mechanism.
ILC2sWere Instrumental for Induction of Th2Cells in the
mLN
To elucidate how ILC2s promote Th2 cell-mediated allergic re-
sponses to papain, we analyzed the initiation of Th2 cell differ-
entiation from naive CD4+ T cells (Figure S4A). Following papain
treatment on days 0 and 1, the numbers of B cells and CD4+
T cells in mLN steadily increased until day 4 (Figure 4A). The in-
duction of Th2 cells was observed by day 6 via intracellular
staining for type 2 cytokines in CD4+ T cells (data not shown).428 Immunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc.CD11c+MHCIIhi activated DCs in the lung rapidly increased in
number, followed by their increase in the mLN (Figure 4A; Fig-
ures S4B and S4C). Thus, papain-activated lung DCs likely
migrated into the draining mLN where they stimulated naive
CD4+ cells. We then compared Th2 cell generation in the
mLN of WT BMT and Rorasg/sg BMT mice 6 days after the initial
papain administration. The in vitro restimulation of mLN lym-
phocytes resulted in substantially lower IL-4, IL-5, and IL-13
production by Rorasg/sg BMT mouse lymphocytes compared
to WT controls (Figures 4B and 4C). Intracellular cytokine stain-
ing also demonstrated that the numbers of CD4+ Th2 cells
expressing IL-5 and IL-13 in the mLNs and lungs of Rorasg/sg
BMT mice were substantially lower than those of WT BMT
mice on day 6 (Figure 4D). Similar results were obtained when
mice were stimulated with house dust mite (HDM) or a fungal
protease-allergen (Figure S4D). Importantly, the adoptive trans-
fer of ILC2s into papain-treated Rorasg/sg BMT mice restored
Th2 cell generation (Figures 4E; Figure S4E). These results
showed that ILC2s were critical for the differentiation of naive
CD4+ T cells into Th2 cells.
Lung ILC2 activation is contingent on stimulation via IL-33, an
alarmin produced in response to a broad range of allergens
(Hardman et al., 2013). We found that papain-driven IL-13 pro-
duction from ILC2, eosinophilic lung inflammation, and Th2 cell
differentiation were all impaired in intranasally challenged IL-
33-deficient mice (Figures S4F-H). Moreover, intranasal admin-
istration of IL-33 alone directly stimulated lung ILC2s without
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Figure 3. IL-4 Played aNonessential Role in the Allergic Response to
Protease Allergen and Induction of Type 2 Lung Inflammation
(A–E) WT (-) and Il4/ (,) mice were treated with papain and analyzed on
day 21 for myeloid cell numbers in the lung and BAL (A), lymphoid cell numbers
in the lung and mLN (B), cytokine concentrations in the BAL (C), and IgE
concentration in serum (D). Intracellular GATA3 was detected in CD4+ T cells
from lung and mLN on day 21 following stimulation with papain, and absolute
numbers of GATA3+ CD4+ T cells were calculated (E).
Data are representative of three independent experiments. Mean ± SEM in
(A)–(E), * = p% 0.05 (two-tailed Student’s t test). See also Figure S3.
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Figure 4. ILC2 Were Instrumental for Induction of Th2 Cells in the
mLN
(A) WTmice received intranasal papain administration on days 0 and 1, and the
absolute numbers of CD4+ T cells, B cells, and MHChi DCs were measured in
the lung (C) or mLN (B) at various time-points by flow cytometry.
(B and C) On day 6, cells from papain-treated WT (-) or Rorasg/sg (,) BMT
mouse mLN were restimulated in aCD3ε and aCD28 mAb coated wells, fol-
lowed by analysis for cytokine production in culture supernatant.
(D) Total numbers of IL-5+IL-13+ CD3+CD4+ Th2 cells from papain treated WT
(-) or Rorasg/sg (,) BMT mouse lung and mLN were measured on day 6.
(E) WT BMT, Rorasg/sg BMT, or ILC2-transplanted Rorasg/sg BMT mice were
stimulated with papain on days 0 and 1, and mLN lymphocytes were analyzed
for intracellular IL-5 and IL-13 on day 6 by flow cytometry (top plots). Gated
IL-5+IL-13+ lymphocytes were analyzed for CD3+CD4+ cells (bottom plots),
and the total numbers of Th2 cells in the mLN were calculated (bar graph).
(F) CFSE-labeled CD4+ T cells fromOT-II mice were transplanted intoWT BMT
and Rorasg/sg BMT mice (±ILC2 transplantation), followed by intranasal in-
jections of rmIL-33 + OVA on days 0 and 1. TCRVb5+CFSE+ OT-II T cells in the
mLN (top plots) were analyzed for intracellular IL-13 (bottom plots) by flow
cytometry on day 6, and the total numbers of IL-13+ OT-II T cells in the mLN
were calculated (bar graph).
Data are representative of at least three independent experiments. Mean ±
SEM in (A)–(F), mean percent gated in (E) and (F), * = p% 0.05 ** = p% 0.01
(two-tailed Student’s t test). See also Figure S4.
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ILC2 Regulates Th2 Cell Differentiationpapain treatment (Figure S4I) as reported (Barlow et al., 2012).
We then intranasally administered ovalbumin (OVA) antigen
together with IL-33 to WT BMT or Rorasg/sg BMT mice, which
were also intravenously injected with carboxyfluorescein succi-
nimidyl ester (CFSE)-labeled CD4+ T cells from the OVA-specific
T cell receptor transgenic OT-II mice. Very few OT-II T cells
(CFSE+) were recovered in the mLNs of Rorasg/sg BMT mice as
compared to WT, and the numbers of IL-4+ IL-13+ Th2 cells
generated in Rorasg/sg BMT mice were substantially lower than
those in WT BMTmice. Moreover, the impaired Th2 cell differen-
tiation was rescued by ILC2 transplantation (Figure 4F). These
results demonstrate that IL-33-mediated ILC2 activation was
critical for effective Th2 cell differentiation, likely in response to
the intranasal administration of a broad range of antigens.
IL-13 from ILC2 Promoted Th2 Cell Differentiation in the
Draining LN
The above results showed that ILC2s promoted Th2 cell differen-
tiation while producing a large amount of IL-13 but little IL-4.
Therefore, we tested whether IL-13 is involved in Th2 cell differ-
entiation in papain-treated mice. Intranasal papain treatment of
IL-13-deficient mice generated substantially fewer Th2 cells
(IL-5+ CD4+ T cells) in themLN compared toWTmice (Figure 5A).
Moreover, IL-13 neutralization also inhibited Th2 cell differentia-
tion in papain-treated WT mice (Figure 5B), whereas IL-13Immunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc. 429
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Figure 5. IL-13 Was Required for Induction of Th2 Cells
(A) WT (-) and Il13/ (,) mice were treated with papain on days 0 and 1, and
the total numbers of IL-5+ CD3+CD4+ Th2 cells in the mLN on day 6 were
measured.
(B) IL-5+IL-13+ CD3+CD4+ Th2 cells were quantified on day 6 after papain stim-
ulation on days 0 and 1 in WTmice (-) or mice treated with anti-IL-13 mAb ( ).
(C) The induction of Th2 cells in WT BMT mice stimulated with papain (-) was
compared toRorasg/sg BMTmice stimulated with papain (,) or papain + rmIL-
13 ( ). The total numbers of IL-5+IL-13+ CD3+CD4+ Th2 cells in the mLN were
quantified on day 6.
(D) CFSE-labeled CD4+ OT-II cells were transplanted into WT and Rorasg/sg
BMTmice, followed by treatment with papain +OVA. On day 6,mLN cells were
analyzed by flow cytometry for CD4+TCRVb5+CFSE+ OT-II T cell proliferation
and intracellular IL-4 and IL-13.
(E)WT (-) andRorasg/sg (,) were treated as in (D). Some of the latter mice also
received rmIL-13 injection ( ). OT-II T cells positively stained for intracellular
IL-4 or IL-13 were quantified and the total numbers of cytokine positive OT-II in
the mLN were calculated.
(F) Rorasg/sg BMT mice were transplanted with CFSE-labeled CD4+ OT-II cells
plus none, WT, or Il13/ ILC2s. These mice were treated on days 0 and 1 with
papain, and CD3+CD4+TCRVb5+CFSE+OT-II T cells in themLNwere analyzed
for intracellular IL-4 and IL-13 (plots) on day 6. The total numbers of IL-4+IL-13+
OT-II T cells in the mLN were calculated (bar graph).
(G) CFSE-labeled CD4+ OT-II cells were transplanted into WT mice. The mice
received intranasal administration of OVA + rmIL-13, OVA alone, or OVA +
papain on days 0 and 1. CD3+CD4+TCRVb5+CFSE+ cells were gated (data not
shown) and analyzed for intracellular IL-4 and IL-13 on day 6 (plots). The total
numbers of IL-4+IL-13+ OT-II T cells in the mLN were calculated (bar graph).
Immunity
ILC2 Regulates Th2 Cell Differentiation
430 Immunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc.injection enabled the generation of Th2 cells in papain-treated
Rorasg/sg BMT mice (Figure 5C).
The role of ILC2-derived IL-13 for Th2 cell differentiation was
confirmed in a TCR-transgenic model, in which CFSE-labeled
OT-II T cells were injected into WT or Rorasg/sg BMT mice. The
mice then received intranasal administration of OVA and papain,
andOT-II T cells in themLNwere analyzed 6 days later. Although
OT-II T cells proliferated in both WT and Rorasg/sg BMTmice, the
differentiation of naive OT-II T cells into Th2 cells was substan-
tially impaired in Rorasg/sg BMT mice (Figure 5D). Notably, this
impaired Th2 cell differentiation in Rorasg/sg BMT mice was
rescued by the intranasal injection of IL-13 (Figure 5E). WT
ILC2 transplantation also rescued Th2 cell production whereas
IL-13-deficient ILC2s did not (Figure 5F). Interestingly, the intra-
nasal administration of OVA alone, without papain, into WT mice
that were injected with CD4+ OT-II T cells did not induce detect-
able Th2 cell differentiation in mLN, whereas the coadministra-
tion of OVA plus IL-13 efficiently induced Th2 cell differentiation
of OT-II T cells (Figure 5G).
Intracellular staining for IL-13 after papain stimulation identi-
fied ILC2 as the primary cellular source, and ILC2-deficient
mice did not produce IL-13 during the acute inflammatory
response (Halim et al., 2012a; 2012b). Analysis of Il13egfp/+ re-
porter mice also confirmed that ILC2s are the predominant Il13
expressing cells in papain-treated lungs (Figure S5A). Together,
these results indicated that ILC2-derived IL-13 was critical for
the differentiation of Th2 cells.
IL-13 Promoted CD40+ DC Migration to the Draining LN
We detected the IL-13 receptor on activated DCs, but not on
CD4+ T cells (Figure S6A), and exogenously added IL-13 did
not have a direct effect on in vitro Th2 cell differentiation (Fig-
ure S6B). Because DCs are known to play a critical role in Th2
cell induction to inhaled allergens (Kool et al., 2012), we hypoth-
esized that ILC2-derived IL-13 might influence DC function. We
first compared DCs in the lungs of WT mice treated with papain
and those treated with heat-inactivated papain and found no dif-
ferences in the expression of CD44, CD86, OX40L, and ICOSL
(data not shown). We then analyzed DCs in the lungs and
mLNs of WT and Rorasg/sg BMT mice treated with papain. No
substantial differences in the number of activated DCs or their
phenotype (CD40 and CCR7 expression) was observed in the
lung between WT BMT and Rorasg/sg BMT mice (Figures 6A-
6C). In contrast, a striking difference in the mLN DC populations
was seen between WT BMT and Rorasg/sg BMT mice. More than
50% of activated DCs in the mLNs of WT BMT mice expressed
CD40, which has been shown to be critical for efficient Th2 cell
differentiation (Jenkins et al., 2008; MacDonald et al., 2002).
Rorasg/sg BMT mice showed substantially reduced CD40+ DC
numbers in the mLN (Figure 6D). Importantly, this impairment
was rescued by IL-13 injection (Figures 6D), whereas IL-13
neutralization substantially reduced CD40+ DCs in the mLN of
papain-treated WT mice (Figure 6E). We also coadministered
papain and the synthetic antigen DQ-OVA, which becomesData are representative of at least three independent experiments. Mean ±
SEM in (A)–(C) and (E)–(G), mean percent gated in (D), (F), and (G), * = p% 0.05
** = p % 0.01, ns = not significant (two-tailed Student’s t test). See also
Figure S5.
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Figure 6. ILC2-Derived IL-13 Promoted DC Migration to the Draining LN
(A–C) Lungs fromWT (red) andRorasg/sg (blue) BMTmice treated on days 0 and 1with papain were analyzed on day 3 for DC activation. CD11c+MHCIIhi activated
DCs were detected by flow cytometry and the total numbers in the lung calculated (A). Activated DCs in (A) were analyzed for CD40 (B) and CCR7 (C) expression.
The red histograms represent WT BMT DCs, the blue histograms represent Rorasg/sg BMT and the solid gray histograms show the FMO control. Bar graphs are
color-coded in the same way show the total numbers of DCs in the lung.
(D) DCs in the mLN of WT and Rorasg/sg BMT mice (±rmIL-13 injection) were analyzed on day 3. Activated CD11c+MHCIIhi DCs gated by red boxes and
nonactivated DCs gated by blue boxes (top plots) were analyzed for CD40 expression (bottom histograms, color-coded in the same way). Number in histogram
shows the percent CD40+CD11c+ cells. Absolute numbers of CD11c+MHCIIhi CD40+ cells in mLN were calculated (bar graph).
(E) WTmice treated with papain (-), papain + anti-IL-13 mAb ( ), or control (,) were analyzed for absolute numbers of activated DCs in mLNs on day 3 as in (D).
(F) Traceable DQ-OVA was injected together with papain into WT (red) or Rorasg/sg (blue) BMTmice, followed by an analysis for DQ-positive CD11c+MHCIIhi DCs
in the lung and mLN on day 3 (histograms), and the total numbers of DQ+ DCs were calculated (bar graph).
(G) Lung tissue explants weremade from papain-stimulatedWT, Il13/, or Il13/ + rmIL-13mice on day 3. Tissue explants were cultured in transwell inserts and
exposed to a CCL21 chemokine gradient for 14 hr. WT lung explants without a CCL21 gradient were used as control. The total number of activated DCs was
counted in both top and bottom compartments by flow cytometry, followed by a calculation of percent DC migration.
(H) Lung tissue explants from naiveWTmicewere stimulated ex vivowith papain for 14 hr in the presence of anti-IL-13 neutralizing antibody ± EP4-agonist or PBS
control. The percent of DC migration toward a CCL21 chemokine gradient was calculated.
(I) Lung explants were prepared, treated with papain in the presence of PBS (control), anti-IL-13 or EP4 antagonist, and DC migration was analyzed as in (H).
Data are representative of at least three independent experiments. Mean ± SEM in (A)–(I), mean percent gated in (A) and (D), ns = not significant * = p% 0.05, ** =
p% 0.01 *** = p% 0.001 (two-tailed Student’s t test). See also Figure S6.
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ILC2 Regulates Th2 Cell Differentiationfluorescent upon processing by antigen-presenting cells, and
analyzed antigen processing by DCs. The processing of antigen
by lung DCs was not affected in Rorasg/sg BMT mice, whereas
the trafficking of DQ-labeled cells to the draining LN was
substantially reduced (Figure 6F). These data suggested that
ILC2-derived IL-13might be critical for the migration of activatedantigen-licensedCD40+DCs from the lung to the drainingmLN in
papain-treated mice.
To further investigate the effect of IL-13 on DC migration,
we prepared lung tissue explants from papain-treated WT or
Il13/ mice and tested the migration of lung tissue-resident
DC toward a gradient of the DC chemokine CCL21 in transwellImmunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc. 431
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ILC2 Regulates Th2 Cell Differentiationcultures (Figures S6C and S6D). CCL21 (or CCL19) signaling via
CCR7 is critical for DC migration to secondary lymphoid organs
(Fo¨rster et al., 1999). DCs in lung tissue explants prepared from
papain-treated WT mice demonstrated robust specific chemo-
taxis in the presence of CCL21, whereas IL-13 had no effect
on its own (Figures S6D and S6E). The migration of Il13/
mouse lung DCs toward CCL21 was substantially lower than
that of WT DCs but was rescued by the administration of recom-
binant IL-13 into the mice (Figure 6G).
It has been reported that prostaglandin E2 (PGE2) signaling
via its receptor, EP4, is necessary to sensitize CCR7+ DCs to a
CCL21 chemokine gradient (Kabashima et al., 2003; Luft et al.,
2002; Scandella et al., 2002). IL-13 is also known to induce
PGE2 production in DCs and macrophages (Legler et al., 2006;
Rey et al., 1999). Indeed, IL-13 stimulation of lung leukocytes
induced PGE2 production (Figure S6F). Gene-expression anal-
ysis indicated high expression of Ptger4 (EP4) by naive lung
DCs (Figure S6G). Furthermore, our flow-cytometric analyses
showed that intranasal IL-13 treatment of mice upregulated
EP4 expression on lung DCs as compared to control PBS-
treated mice (Figure S6H). Thus, we tested whether EP4 was
involved in DC migration in our system by using lung explant
cultures of naive WT mice. The in vitro DC migration was sub-
stantially inhibited by IL-13 neutralization but was rescued by
simultaneously adding an EP4-agonist (Figure 6H). EP4-antago-
nist also mimicked IL-13-neutralization and substantially in-
hibited DCmigration (Figure 6I). Overall, these results suggested
that IL-13 influenced lung DC migration, in part by modifying the
PGE2-EP4 pathway.
The migration of activated DCs to the draining LN is thought to
be essential for the induction of Th2 cell differentiation (Phythian-
Adams et al., 2010; van Rijt et al., 2005). Indeed, papain-stimu-
lated mLN DCs efficiently induced Th2 cell differentiation
in vitro (Figure S6I). Furthermore, papain-induced Th2 cell-medi-
ated allergic lung inflammation was impaired in the LN-deficient
Rag2/Il2rg/mice transplanted withWT or Rorasg/sg BM (Fig-
ures S6J–S6M). Thus, the migration of activated lung DCs to the
mLN was critical for the initiation of Th2 cell differentiation
induced by inhaled allergens.
DISCUSSION
By using ILC2-deficient mice generated by transplanting BM of
the Rora mutant Staggerer mice into irradiated recipients, we
have demonstrated that ILC2s were required for efficient Th2
cell-mediated allergic lung inflammation induced by repeated
intranasal administration of the protease-allergen papain. The
inability of ILC2-deficient mice to mount strong allergic lung
inflammation in response to intranasal papain was due to
impaired Th2 cell differentiation in the draining mLN, and could
be rescued in vivo by reconstituting ILC2s. Therefore, ILC2s
played a critical role in the differentiation of naive CD4+ T cells
into Th2 cells. Although IL-4 is thought to be critical for Th2 cell
differentiation, the Th2 cell-promoting effect of ILC2s appeared
to be mediated by IL-13 rather than IL-4, because IL-4-deficient
mice mounted a potent Th2 cell-mediated response to papain,
whereas IL-13-deficient mice did not. Furthermore, the intra-
nasal administration of IL-13 into ILC2-deficient mice enabled
these mice to mount a normal Th2 cell response to papain,432 Immunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc.whereas IL-13 neutralization in WT mice inhibited the papain-
induced Th2 cell response. The transplantation of IL-13-deficient
ILC2s into ILC2-deficient mice, unlike WT ILC2 transplantation,
did not rescue this impaired Th2 cell differentiation, and the intra-
nasal administration of IL-13 and OVA without papain into WT
mice also promoted OVA-specific OT-II T cell differentiation
into Th2 cells. Taken together, these results indicate that ILC2-
derived IL-13 was critical for the differentiation of naive CD4+
T cells into Th2 cells in the mLN.
IL-13 is known to be a pro-Th2 cytokine (Wynn, 2003). The
neutralization of IL-13 inhibits asthma symptoms in OVA-sensi-
tized and challenged mice (Gru¨nig et al., 1998), and IL-13-
deficient mice have an impaired Th2 cell response to parasite
infections (McKenzie et al., 1998). However, the source of
IL-13 and the mechanisms by which IL-13 promotes Th2 cell
differentiation have remained unclear. In the current study with
papain-treated mice, ILC2s were the main source of IL-13.
Although basophils and mast cells are also known to be capable
of producing IL-13 (Kroeger et al., 2009), they were undetectable
in papain-treated mouse lungs or mLNs. The receptor for IL-13
consists of IL-4Ra and IL-13Ra (Mentink-Kane and Wynn,
2004). DCs expressed IL-13Ra1, which was undetectable on
naive CD4+ T cells. IL-13 also had no effect on Th2 cell differen-
tiation in vitro (Figure S6, also [McKenzie et al., 1998]), indicating
that IL-13 is unlikely to act directly on naive CD4+ T cells. Instead,
DCs seemed to be the main target of ILC2-derived IL-13 in
papain-treated mice. DCs in the draining mLN of WT and ILC2-
deficient mice treated with papain differed substantially in their
expression of the costimulatory ligand CD40. The effects of
IL-13 administration on ILC2-deficient mice and IL-13 neutraliza-
tion in WT mice indicated that ILC2-derived IL-13 was likely
responsible for CD40+ DCs in the mLN. However, ILC2-derived
IL-13 did not appear to directly induce CD40 expression on
DCs, because DCs in the lungs of WT and ILC2-deficient mice
treated with papain did not differ substantially in their expression
of CD40 or their processing of antigen (DQ-OVA). Instead, IL-13
appeared to stimulate the migration of activated DCs expressing
CD40 from the lung to the mLN.
Our in vitro studies with Il13/ lung explants and IL-13-
neutralization demonstrated that IL-13 plays an important role
for lung DC migration toward the DC chemokine CCL21, which
binds to its receptor, CCR7 (Fo¨rster et al., 1999). Although
CCR7 is known to be critical for DC migration to the draining
LN,WT and ILC2-deficient mice treated with papain did not differ
in terms of lung DC CCR7 expression. It has been reported that
CCR7 expression alone is insufficient for skin DC migration to-
ward a CCL21 chemokine gradient, requiring additional stimuli,
which can be provided by the ligation of the PGE2-receptor
EP4 (Kabashima et al., 2003; Luft et al., 2002; Scandella et al.,
2002). Because IL-13 stimulates the production of PGE2 by
DCs and macrophages (Legler et al., 2006; Rey et al., 1999), it
is possible that this is the mechanism by which IL-13 promotes
DC migration to the draining LN. The effects of a EP4 agonist
and antagonist on DC migration in vitro, as well as EP4 upregu-
lation, and PGE2 production by IL-13 treatment further sup-
ported the notion that IL-13 promotes CCR7+ DC migration, in
part through its influence on the EP4-PGE2 pathway.
It is well established that tissue DCs encountering antigens
migrate to draining LNs, where they present antigens to naive
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the importance of LNs as the site of Th2 cell differentiation.
Repeated intranasal papain treatment induced much weaker
allergic lung inflammation in Rag2/Il2rg/ mice transplanted
with WT BM cells than that in irradiated congenic WT recipient
mice. We have previously shown that the former mice have
normal ILC2s and other lymphocytes (Halim et al., 2012b). We
believe that the observed differences are due to the lack of
LNs in the former mice. Although papain treatment activated
lung DCs, antigen presentation within the lung appeared to be
very inefficient compared to antigen presentation in the draining
mLN, and the migration of activated DCs into the mLN was crit-
ical for efficient activation of naive CD4+ T cells.
It remains to be determined whether CD40 on DCs is directly
responsible for the differentiation of naive CD4+ T cells into Th2
cells in papain-treated mice. Studies with CD40-deficient
DCs show that the interaction between CD40 and its ligand
(CD154) is required for Th2, but not Th1, cell responses
(MacDonald et al., 2002). However, CD154 expression on
CD4+ cells is not essential for Th2 cell differentiation (Jenkins
et al., 2008). Several other costimulatory receptor-ligand combi-
nations, including ICOS-ICOSL (Tafuri et al., 2001) and OX40-
OX40L (Jenkins et al., 2007), are also known to be involved
in Th2 cell differentiation. However, how signals generated by
these costimulatory receptor-ligand interactions in naive CD4+
T cells lead to GATA3 activation, which is critical for Th2 cell
differentiation (Paul, 2010), are currently unknown. While the
precise mechanisms by which Th2 cell differentiation is initiated
in the mLN of papain-treated mice is still unclear, it should
be noted that papain treatment or IL-13 administration does
not induce IL-12p40 or IL-12p35 expression, which is thought
to be critical for Th1 cell differentiation. IL-12p40 neutralization
also had no effect on papain induced DC migration (data not
shown).
We have also demonstrated that ILC2 activation and Th2
cell differentiation in papain-treated mice was IL-33-dependent.
IL-33, which is considered to be an alarmin, is constitutively
expressed in the nuclei of airway epithelial cells and rapidly
released upon epithelial cell damage. Papain, but not heat-inac-
tivated papain, activated ILC2s in WT mice but not IL-33-defi-
cient mice, indicating that the protease activity of papain likely
caused epithelial cell damage and IL-33 release, which in
turn activated ILC2s. Indeed, intranasal administration of IL-33
directly stimulated ILC2s to produce IL-13, and coadministration
of OVA and IL-33 promoted OVA-specific OT-II T cell differenti-
ation into the Th2 cell pathway. These results suggested that any
antigens that cause airway epithelial cell damage and/or activa-
tion and induce IL-33 release, and subsequent activation of
ILC2s, could be potential allergens. Thus, the cascade of cell
activation and cytokine production, initiated by airway epithelial
IL-33 release, IL-13 production by ILC2s and downstream Th2
cell differentiation, type 2 cytokine production and IgE produc-
tion is likely a common pathway of allergic lung inflammation
in response to a broad range of allergens. Indeed, we also
observed reduced Th2 cell differentiation in responses to both
HDM extract and Aspergillus sp. protease allergens in the
absence of ILC2s.
In summary, this study has revealed a critical role of ILC2s in
the differentiation of naive CD4+ T cells into Th2 cells in responseto protease allergens in the lung, thus providing an important
clue to the long-standing question of why airway allergens
induce an adaptive Th2 cell response. Our results redraw the
map of type 2 immunity, placing ILC2s at the center of a common
pathway of the Th2 cell cascade for a range of allergens. As one
of the early and critical ‘‘domino tiles,’’ ILC2s likely exert a pro-
found effect on Th2 cell-mediated inflammatory diseases such
as asthma.
EXPERIMENTAL PROCEDURES
Mice
C57Bl/6 (B6), B6-Tg(TcraTcrb)425Cbn/J (OT-II), B6.Pep3b, and B6.Il33/ (KOMP)
mice were maintained in the BCCRC animal facility, and B6.Il13egfp/egfp were
maintained in the MRC ARES animal facility, under SPF conditions.
B6.Il4tm1Nnt/J, B6.129S7-Rag1tm1Mom/J and B6.Cg-Rorasg/J mice were pur-
chased from the Jackson Laboratories. B6.Rag2/Il2rg/ mice were pur-
chased from Taconic Farms. Mice were used at 4–8 weeks of age. All animal
use was approved by the animal care committee of the University of British
Columbia in accordance with the guidelines of the Canadian Council on Animal
Care or the UK Home Office.
Bone Marrow Transplantation
B6.Rag2/Il2rg/ or B6.Pep3bmicewere lethally irradiated (10Gy), followed
by intravenous transplantation of 107 whole bone-marrow cells from 3- to
4-week-old mice. Mice were given ciprofloxacin and HCl in drinking water
for 4 weeks, and used for analysis at 8–16 weeks posttransplant.
Primary Leukocyte Preparation
Cell suspensions were prepared from the lungs, spleens, LNs, or BM as pre-
viously described (Veinotte et al., 2008).
Intracellular Staining
Intracellular staining for GATA3 was performed with the Foxp3 intracellular
staining kit (eBioscience) according to the manufacturer’s protocol. Intracel-
lular staining for IL-4, IL-5, IL-13, and IFN-g was performed with the Cytofix/
Cytoperm kit (BD Biosciences) after 3 hr restimulation of 2 3 106 total live
nucleated cells in 500 ml RPMI-1640 media containing 10% FBS, Penicillin/
Streptomycin (P+S), 2-mercaptoethanol (2-ME), Brefeldin A (GolgiPlug, BD
Biosciences) or eBioscience protein transport inhibitor cocktail (for intracel-
lular IL-4 detection), PMA (30 ng/ml), and ionomycin (500 ng/ml) at 37C.
Dead cells were excluded with eFluor 450 or eFluor 780 (eBioscience)
fixable viability dye.
Isolation of ILC2
Single cells were incubated with 2.4G2 to block Fc receptors and then stained
with eFluor 450-conjugated lineage marker mAbs (CD3ε, CD19, B220,
NK1.1, Mac-1, GR-1, and Ter119), APC-eFluor 780-conjugated B220, PE-
conjugated CD127, PerCP-Cy5.5-conjugated CD25, PE.Cy7-conjugated
Sca-1, and APC-conjugated CD117, V500-conjugated CD45, FITC-conju-
gated T1/ST2, PI viability dye, and purified by FACS.
Lung Explant Cultures
Lung explants were made by injecting mouse lungs with 2% low melting point
agarose (in RPMI-1640, kept at 37C) via intratracheal injection. Lungs were
allowed to cool, after which they were dissected. Explants of 300 mm thickness
were made using a vibratome (Leica). Explants were cultured in 5.0 mm pore-
size hanging-cell-culture inserts (Millipore) in RPMI-1640 media (10% FCS,
P+S, 2 ME). Papain (5 mg/ml), anti-IL13 (0.5 mg/ml), rIL-13 (10 ng/ml), EP4-
agonist (5 mM), or EP4-antagonist (5 mM) was added to the media. CCL21 or
rmIL-13 (100 ng/ml) was added to the bottom compartment of the trans-well
culture. Explants were cultured at 37C for 14 hr. All contents of the trans-
well inserts (including explants) were harvested and made to single-cell
suspension, followed by Percoll purification of cells. All migrated cells in the
bottom compartment were harvested. Cells were FcR-blocked and stained
with PI, anti-CD11c, MHCII, B220, and CD45, followed by analysis by flowImmunity 40, 425–435, March 20, 2014 ª2014 Elsevier Inc. 433
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beads (Invitrogen). The percent of migrated DCs in each culture was
calculated.
In Vivo Stimulation
Mice were anesthetized by isofluorane inhalation, followed by the intranasal
administration of rmIL-13 (1 mg), rmIL-33 (0.5 mg), OVA (50 mg), DQ-OVA
(50 mg), house dust mite extract (100 mg), Aspergillus oryzae protease allergen
(10 mg), papain, or heat-inactivated papain (10 mg) in 40 ml of PBS. Cultured
ILC2s were adoptively transplanted (105 cells) on days 0 and 1 by tail vein
injection. Mice were sacrificed at indicated times, and spleens, pLNs, lungs,
mLNs, and BAL (1 ml PBS) were collected or airways were instilled with
50:50 Tissue-Tek O.C.T. Compound (Adwin Scientific) and PBS and fixed
in formalin.
OT-II Adoptive Transplant
OT-II cells were purified by CD4+ negative selection (StemCell Technologies)
from OT-II mouse spleen. CD4+ OT-II cells were counted and labeled with
CFSE (Invitrogen). On day 0, recipient mice were injected with 1 3 106 CFSE
labeled OT-II cells by tail vein injection.
Statistics
Data were analyzed with GraphPad Prism 6 (GraphPad Software). A Student’s
t test was used to determine statistical significance between two groups, and
ANOVA was performed for multivariable analysis, with p% 0.05 being consid-
ered significant.
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